Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,880 (market cap 166.97T, 197.42M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 1005.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (197.42M versus 324K). Which is the better fit depends on your goals.
| OBAT | TPIA | |
|---|---|---|
Market Cap | 166.01B | 166.97T |
Volume | 324K | 197.42M |
Lot | 3.24K | 1.97M |
Turnover | 77.68M | 373.29B |
Average Price | 239.75 | 1,890.87 |
Value | 77.68M | 373.29B |
Indicative Equilibrium Price | 240 | 1,880 |
Indicative Equilibrium Volume | 1 | 33.45K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Chandra Asri Pacific Tbk.
PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →
